Celsius (NASDAQ:CELH) Given New $47.00 Price Target at B. Riley

Celsius (NASDAQ:CELH) had its price objective reduced by B. Riley from $50.00 to $47.00 in a report released on Monday, Benzinga reports. They currently have a buy rating on the stock. B. Riley also issued estimates for Celsius’ Q3 2024 earnings at $0.02 EPS, FY2024 earnings at $0.65 EPS, FY2025 earnings at $0.71 EPS and FY2026 earnings at $1.09 EPS.

Other equities analysts have also recently issued reports about the stock. Morgan Stanley reaffirmed an “equal weight” rating and set a $50.00 target price on shares of Celsius in a research note on Tuesday, August 20th. Piper Sandler dropped their price objective on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a research note on Tuesday, September 24th. Stifel Nicolaus dropped their price objective on Celsius from $61.00 to $51.00 and set a “buy” rating for the company in a report on Thursday, September 5th. Maxim Group reduced their target price on shares of Celsius from $65.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, September 5th. Finally, UBS Group decreased their price objective on Celsius from $70.00 to $64.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Celsius has a consensus rating of “Moderate Buy” and an average target price of $56.27.

Celsius Price Performance

Shares of NASDAQ:CELH opened at $31.07 on Monday. The stock’s fifty day moving average price is $32.81 and its 200-day moving average price is $52.06. Celsius has a 1 year low of $28.20 and a 1 year high of $99.62. The company has a market cap of $7.24 billion, a P/E ratio of 30.56, a PEG ratio of 2.45 and a beta of 1.86.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.23 by $0.05. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The firm had revenue of $402.00 million during the quarter, compared to analyst estimates of $391.07 million. During the same period in the prior year, the business posted $0.17 EPS. Celsius’s revenue was up 23.4% on a year-over-year basis. On average, sell-side analysts anticipate that Celsius will post 0.79 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO John Fieldly sold 74,847 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at $59,449,672. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Celsius

A number of hedge funds have recently modified their holdings of the business. FinTrust Capital Advisors LLC acquired a new stake in shares of Celsius during the first quarter valued at about $25,000. S.A. Mason LLC acquired a new stake in Celsius in the 2nd quarter valued at approximately $30,000. EverSource Wealth Advisors LLC boosted its position in shares of Celsius by 3,116.7% during the first quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after buying an additional 374 shares during the period. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Celsius in the third quarter valued at $34,000. Finally, Signaturefd LLC raised its holdings in shares of Celsius by 48.3% in the 3rd quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock valued at $36,000 after buying an additional 378 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.